BioXcel Therapeutics, Inc. (NASDAQ:BTAI – Get Rating) saw a large growth in short interest during the month of May. As of May 31st, there was short interest totalling 3,720,000 shares, a growth of 11.0% from the May 15th total of 3,350,000 shares. Based on an average daily volume of 596,900 shares, the short-interest ratio is […]
BioXcel Therapeutics, Inc. (NASDAQ:BTAI – Get Rating) saw a significant increase in short interest during the month of May. As of May 31st, there was short interest totalling 3,720,000 shares, an increase of 11.0% from the May 15th total of 3,350,000 shares. Based on an average daily trading volume, of 596,900 shares, the days-to-cover ratio […]
Shares of BioXcel Therapeutics, Inc. (NASDAQ:BTAI – Get Rating) have received an average rating of “Moderate Buy” from the seven ratings firms that are presently covering the firm, Marketbeat Ratings reports. Two analysts have rated the stock with a hold rating and three have issued a buy rating on the company. The average 12 month […]
BioXcel Therapeutics, Inc. (NASDAQ:BTAI – Get Rating)’s share price dropped 10.8% during trading on Thursday following insider selling activity. The stock traded as low as $23.05 and last traded at $23.14. Approximately 268,968 shares traded hands during mid-day trading, a decline of 43% from the average daily volume of 469,346 shares. The stock had previously […]
BioXcel Therapeutics, Inc. (NASDAQ:BTAI – Get Rating) insider Javier Rodriguez sold 1,785 shares of the company’s stock in a transaction that occurred on Monday, May 15th. The stock was sold at an average price of $27.32, for a total transaction of $48,766.20. Following the sale, the insider now owns 4,350 shares in the company, valued […]